CIK 0001609809
- Non-accelerated filer
- Smaller reporting company
Seres Therapeutics, Inc.
Sign in to watch- Ticker
- MCRB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 274326290
- Phone
- +1 617-945-9626
- Business address
- 200 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- Seres Therapeutics, Inc., Seres Health, Inc.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3/A Insider 3/A
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Legal Officer and EVP sold 5,471 shares at $5.75 ($31,478)
- 4 Open-market sale Shaff Eric D. sold 4,378 shares at $5.75 ($25,188)
- 4 Exercise or conversion Chief Technology Officer acquired 7,500 shares (option exercise)
- 4 Exercise or conversion COOK DAVID N acquired 7,500 shares (option exercise)
- 4 Open-market sale Chief Technology Officer & EVP sold 14,282 shares at $6.39 ($91,313)
- 4 Open-market sale Aunins John G. sold 14,279 shares at $8.26 ($117,912)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Aunins John G. sold 14,279 shares at $5.94 ($84,800)
- 4 Open-market sale Aunins John G. sold 42,837 shares at an average $7.64 ($327,345)
- 4 Open-market sale President and CEO sold 1,810 shares at $9.00 ($16,291)
- 4 Open-market sale President and CEO sold 12,518 shares at an average $9.10 ($113,950)
- 4 Derivatives Options or other derivatives
Page 13 of 19 · 380 filings